Ranking results:

Past rankings:

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0^*

^*Ratio includes only projects with > 2 partners

Summary:

	Total project funding [€]:			Projects [No]:
Year:	coordinator^*	participant^*	per partner	as coordinator	as participant
2013	0	5.998.984	1.114.103		1
2012	0	5.299.478	83.801		1

^*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:	Projects [No]:
EURAM LIMITED	2
MAGNUS INVENTION MANAGEMENT	2
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON	2
UNIVERSITY COLLEGE LONDON	2
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER	1
ITAE SUOMEN YLIOPISTO	1
ITASUOMEN YLIOPISTO	1
LUNDS UNIVERSITET	1
QUALIMED INNOVATIVE MEDIZINPRODUKTE	1
UNIVERSITAETSKLINIKUM HAMBURGEPPENDORF	1
UNIVERSITY COLLEGE LONDON HOSPITALSNHS FOUNDATION TRUST	1
YALE UNIVERSITY	1

Constancy:

Total number of partners: 16
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 16
Frequent / Rare Partner Ratio: 0

Project overview:

Start date	Project	acronym	role	funding	partners
2013-01-01	Does vascular endothelial growth factor gene therapy safely improve outcome in severe early-onset fetal growth restriction?	EVERREST	participant	5.998.984	10
2012-01-01	Biodegradable Magnetic Stent for Coronary Artery Luminal Regeneration	BIOMAGSCAR	participant	5.299.478	8

FINVECTOR VISION THERAPIES LIMITED - United Kingdom